Companies · Other Health Care

Ontrak, Inc.

SANTA MONICA · Other Health Care

Diligence memoA one-page analyst read on Ontrak, Inc. — recommendation, valuation, rhythm, risks.
$45.1M
Total raised · real
20
Rounds
1.3×
Latest step-up
Top 10%
Sector rank · raised
Series A
Latest stage · inferred · Wed Oct 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Ontrak, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.08× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
  • Within the normal band (108% of peer median) for its niche.
Dormant
  • Last raise 5.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Ontrak, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
15.7 yr record
Peak capital year was 2020 with $10.7M across 2 filings.
Market position
ahead of 91% of Other Health Care peers
Capital scale is ahead of 91% of Other Health Care peers; modeled value is above 81% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2020: $10.7M across 2 filings.
  • Largest single filing was $6.9M on 2010-11-12.
  • Filing rows sum to $50.6M, while canonical raised total is $45.1M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Ontrak, Inc. is one of 5376 Other Health Care companies tracked from SANTA MONICA. By capital raised it ranks among the largest (ahead of 91% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
21
Investors (latest)
2020-10-28
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2010-10-19 Raised $500K (real) Modeled valuation $15M (est)Pre-Seed2010Series A · 2010-11-12 Raised $6.9M (real) Modeled valuation $140M (est)Series A · 2011-07-01 Raised $128K (real) Modeled valuation $2.6M (est)Series A2011Series A · 2011-08-17 Raised $650K (real) Modeled valuation $13M (est)Series A · 2011-09-22 Raised $225K (real) Modeled valuation $4.5M (est)Series A2011Series A · 2011-10-05 Raised $680K (real) Modeled valuation $14M (est)Pre-Seed · 2012-02-22 Raised $775K (real) Modeled valuation $24M (est)Pre-Seed2012Series A · 2012-02-22 Raised $975K (real) Modeled valuation $20M (est)Series A · 2012-04-17 Raised $3.4M (real) Modeled valuation $69M (est)Series A2012Series A · 2012-09-13 Raised $1.7M (real) Modeled valuation $35M (est)Series A · 2012-12-04 Raised $3.3M (real) Modeled valuation $67M (est)Series A2012Series A · 2013-04-10 Raised $1.5M (real) Modeled valuation $31M (est)Series A · 2013-10-02 Raised $2.6M (real) Modeled valuation $53M (est)Series A2013Series A · 2014-01-31 Raised $1.0M (real) Modeled valuation $20M (est)Series A · 2014-05-27 Raised $1.5M (real) Modeled valuation $30M (est)Series A2014Series A · 2014-09-29 Raised $1.5M (real) Modeled valuation $30M (est)Series A · 2014-12-22 Raised $1.1M (real) Modeled valuation $22M (est)Series A2014Series A · 2015-04-16 Raised $2.1M (real) Modeled valuation $43M (est)Series A · 2015-07-30 Raised $3.6M (real) Modeled valuation $72M (est)Series A2015Series A · 2016-12-21 Raised $5.6M (real) Modeled valuation $112M (est)Series A · 2020-10-28 Raised $4.6M (real) Modeled valuation $83M (est)Series A2020Series A · 2020-10-28 Raised $6.1M (real) Modeled valuation $109M (est)Cumulative $51M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$500K · 2010
Series A$6.9M · 2010no Seed on file
Series A extension$128K · 2011
Series A extension$650K · 2011
Series A extension$225K · 2011
Series A extension$680K · 2011
Bridge · Series A-stage$775K · 2012smaller follow-on
Series A extension$975K · 2012
Series A extension$3.4M · 2012
Series A extension$1.7M · 2012
Series A extension$3.3M · 2012
Series A extension$1.5M · 2013
Series A extension$2.6M · 2013
Series A extension$1.0M · 2014
Series A extension$1.5M · 2014
Series A extension$1.5M · 2014
Series A extension$1.1M · 2014
Series A extension$2.1M · 2015
Series A extension$3.6M · 2015
Series A extension$5.6M · 2016
Series A extension$4.6M · 2020
Series A extension$6.1M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$109.1M
Base estimate est.
$7.8M
Conservative case
$550.1M
Upside case
$27.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $15.4M · 2010-10-192010Series A · modeled $140.2M · 2010-11-12Series A · modeled $2.6M · 2011-07-01Series A · modeled $13.1M · 2011-08-17Series A · modeled $4.5M · 2011-09-22Series A · modeled $13.7M · 2011-10-05Pre-Seed · modeled $23.9M · 2012-02-22Series A · modeled $19.7M · 2012-02-22Series A · modeled $69.2M · 2012-04-17Series A · modeled $34.7M · 2012-09-13Series A · modeled $66.6M · 2012-12-04Series A · modeled $31.0M · 2013-04-10Series A · modeled $53.3M · 2013-10-02Series A · modeled $20.2M · 2014-01-31Series A · modeled $30.3M · 2014-05-27Series A · modeled $30.3M · 2014-09-29Series A · modeled $22.2M · 2014-12-22Series A · modeled $42.8M · 2015-04-16Series A · modeled $71.7M · 2015-07-30Series A · modeled $112.3M · 2016-12-21Series A · modeled $83.2M · 2020-10-28Series A · modeled $109.1M · 2020-10-282020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
5.7 yr
Elapsed time used
5.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$4.5M/yr
Capital velocity
15.7 yr
On record since
2010
First round
22
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 19× above median
This company$45.1M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.1× above median
This company$6.1M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 4.9× above median
This company$109.1M
Sector median$22.1M

Raised more than 91% of sector peers (real $). Modeled value above 81% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #70 of 164.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $259.8M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.4M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.1M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.3M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)Ontrak, Inc. (this company) Raised $45.1M · modeled $109.1M (est)Ontrak, Inc.
CompanyStageRaised · realValue · estvs peer med.
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$259.8M2.57×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.4M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.1M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.3M2.19×
Zipari, Inc.Series A$29.6M$208.3M2.06×
Ontrak, Inc. this companySeries A$45.1M$109.1M1.08×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$500K2010-10-19$2.8M$15.4M85%
Series A$6.9M2010-11-12$31.6M$140.2M85%
Series A$128K2011-07-01$580K$2.6M85%
Series A$650K2011-08-17$3.0M$13.1M85%
Series A$225K2011-09-22$1.0M$4.5M85%
Series A$680K2011-10-05$3.1M$13.7M85%
Pre-Seed$775K2012-02-22$4.3M$23.9M85%
Series A$975K2012-02-22$4.4M$19.7M85%
Series A$3.4M2012-04-17$15.6M$69.2M85%
Series A$1.7M2012-09-13$7.8M$34.7M85%
Series A$3.3M2012-12-04$15.0M$66.6M85%
Series A$1.5M2013-04-10$7.0M$31.0M85%
Series A$2.6M2013-10-02$12.0M$53.3M85%
Series A$1.0M2014-01-31$4.5M$20.2M85%
Series A$1.5M2014-05-27$6.8M$30.3M85%
Series A$1.5M2014-09-29$6.8M$30.3M85%
Series A$1.1M2014-12-22$5.0M$22.2M85%
Series A$2.1M2015-04-16$9.6M$42.8M85%
Series A$3.6M2015-07-30$16.2M$71.7M85%
Series A$5.6M2016-12-21$25.3M$112.3M90%
Series A$4.6M2020-10-28$21.1M$83.2M90%
Series A$6.1M2020-10-28$27.6M$109.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$500K2010-10-19
    • First recorded raise — entered as Pre-Seed.
    • 2 investors on this round.
  2. Series A$6.9M2010-11-12
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 13.9× larger than the prior — scaling up.
    • 22 investors on this round.
  3. Series A$128K2011-07-01
    • Came back fast: 8 mo vs the ~14 mo sector norm.
    • Round 54.5× smaller than the prior — bridge or down round.
    • Revenue band moved $1M–$5M → $0–$1M.
    • 2 investors on this round.
  4. Series A$650K2011-08-17
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 5.1× larger than the prior — scaling up.
    • 1 investor on this round.
  5. Series A$225K2011-09-22
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 2.9× smaller than the prior — bridge or down round.
    • 1 investor on this round.
  6. Series A$680K2011-10-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.0× larger than the prior — scaling up.
    • 1 investor on this round.
  7. Pre-Seed$775K2012-02-22
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  8. Series A$975K2012-02-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  9. Series A$3.4M2012-04-17
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 3.5× larger than the prior — scaling up.
    • 6 investors on this round.
  10. Series A$1.7M2012-09-13
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  11. Series A$3.3M2012-12-04
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • 11 investors on this round.
  12. Series A$1.5M2013-04-10
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 2.1× smaller than the prior — bridge or down round.
    • 6 investors on this round.
  13. Series A$2.6M2013-10-02
    • Came back fast: 6 mo vs the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 06).
    • 7 investors on this round.
  14. Series A$1.0M2014-01-31
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 2.6× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  15. Series A$1.5M2014-05-27
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 9 investors on this round.
  16. Series A$1.5M2014-09-29
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 8 investors on this round.
  17. Series A$1.1M2014-12-22
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  18. Series A$2.1M2015-04-16
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 1.9× larger than the prior — scaling up.
    • Revenue band moved $0–$1M → $1M–$5M.
    • Switched to Rule 506(c) (was Rule 506(b)).
    • 4 investors on this round.
  19. Series A$3.6M2015-07-30
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 1.7× larger than the prior — scaling up.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 1 investor on this round.
  20. Series A$5.6M2016-12-21
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 1.6× larger than the prior — scaling up.
    • 4 investors on this round.
  21. Series A$4.6M2020-10-28
    • Raised again after 46 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • 18 investors on this round.
  22. Series A$6.1M2020-10-28
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 21 investors on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~6mo cadence
$8.0M
Modeled next size est.range $6.1M$12.8M
1.3×
Last step-up
$4.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Richard Anderson9 other2013-10
David A. Smith4 other2015-04
David E. Smith3 other2014-05
Edward J Zecchini3 other2020-10
Terren Peizer3 other2013-10
Terren S. Peizer3 other2010-10
Steven A. Kriegsman2 other2015-04
Andrea Barthwell1 other2013-10
Jay A. Wolf1 other2010-10
Kelly McCrann1 other2013-10
Richard A. Berman1 other2015-04
Andrea G. Barthwell2010-10
Arik Louise Hill2020-10
Brandon H. LaVerne2020-10
Curt B. Medeiros2020-10
Diane B. Seloff2020-10
Edward B. Zecchini2020-10
Gus A. Giraldo2020-10
Gustavo A. Giraldo2020-10
James J. Park2020-10
Jonathan H. Mayhew2020-10
Katherine B. Quinn2020-10
Kelly G. McCrann2011-07
Marc G. Cummins2010-10
Registry & provenance

Ontrak, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1136174
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Remedy Partners, Inc.Other Health CareSeries B$56.4M$795.3Mnetwork1 shared operator · same sector
Zyga Technology, Inc.Other Health CareSeries A$46.8M$100.9Msame sector · same stage
Biovie Inc.BiotechnologySeries A$10.5M$81.1Mnetwork2 shared operators · same stage
Carena IncOther Health CareSeries A$37.2M$121.1Msame sector · same stage
BeneChill, Inc.Other Health CareSeries A$35.7M$132.7Msame sector · same stage
Light Wave Holding Company, LLCOther Health CareSeries B$82.9M$11.7Mnetwork1 shared operator · same sector
MDSave, Inc.Other Health CareSeries A$32.5M$97.4Msame sector · same stage
Sunniva Inc.Other Health CareSeries A$32.2M$121.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
OnLume Inc.Other Health CareSeries A$23.2M87%
OncoTracker, Inc.Other Health CareSeed$3.7M87%
SafeTraces, Inc.Other Health CareSeries A$201.8M86%
Eyenuk, Inc.Other Health CareSeries B$262.6M85%
Endolumik, Inc.Other Health CareSeed$4.5M85%
Neotract IncOther Health CareSeries C$293.0M85%
Ondello, Inc.Other Health CareSeed$50.4M85%
Lifespark Holdings, Inc.Other Health CareSeries B$261.5M84%
Frequently asked
How much funding has Ontrak, Inc. raised?
Ontrak, Inc. has raised approximately $45.1M in disclosed capital across 20 recorded financing rounds, aggregated from public filings.
What is Ontrak, Inc.'s estimated valuation?
Provath's modeled valuation for Ontrak, Inc. is approximately $109.1M (modeled range $7.8M–$550.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Ontrak, Inc. at?
Ontrak, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Oct 28.
What does Ontrak, Inc. do and where is it based?
Ontrak, Inc. operates in the Other Health Care sector, based in SANTA MONICA.
Explore related

See where Ontrak, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Ontrak, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.